Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Roche Registration GmbH, Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Germany
Tamiflu 30 mg hard capsules.
Tamiflu 45 mg hard capsules.
Tamiflu 75 mg hard capsules.
| Pharmaceutical Form |
|---|
|
Tamiflu 30 mg hard capsules: The hard capsule consists of a light yellow opaque body bearing the imprint “ROCHE” and a light yellow opaque cap bearing the imprint “30 mg”. Imprints are blue. Tamiflu 45 mg hard capsules: The hard capsule consists of a grey opaque body bearing the imprint “ROCHE” and a grey opaque cap bearing the imprint “45 mg”. Imprints are blue. Tamiflu 75 mg hard capsules: The hard capsule consists of a grey opaque body bearing the imprint “ROCHE” and a light yellow opaque cap bearing the imprint “75 mg”. Imprints are blue. |
Tamiflu 30 mg hard capsules: Each hard capsule contains oseltamivir phosphate equivalent to 30 mg of oseltamivir.
For the full list of excipients, see section 6.1.
Tamiflu 45 mg hard capsules: Each hard capsule contains oseltamivir phosphate equivalent to 45 mg of oseltamivir.
For the full list of excipients, see section 6.1.
Tamiflu 75 mg hard capsules: Each hard capsule contains oseltamivir phosphate equivalent to 75 mg of oseltamivir.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Oseltamivir |
Oseltamivir (oseltamivir carboxylate) is a selective inhibitor of influenza virus neuraminidase enzymes, which are glycoproteins found on the virion surface. Viral neuraminidase enzyme activity is important both for viral entry into uninfected cells and for the release of recently formed virus particles from infected cells, and for the further spread of infectious virus in the body. |
| List of Excipients |
|---|
Tamiflu 30 mg hard capsulesCapsule core: Pregelatinised starch (derived from maize starch) Capsule shell: Gelatin Printing ink: Shellac Tamiflu 45 mg hard capsulesCapsule core: Pregelatinised starch (derived from maize starch) Capsule shell: Gelatin Printing ink: Shellac Tamiflu 75 mg hard capsulesCapsule core: Pregelatinised starch (derived from maize starch) Capsule shell: Gelatin Printing ink: Shellac |
Triplex blister pack (PVC/PE/PVDC, sealed with aluminium foil). Pack-size 10 capsules.
Roche Registration GmbH, Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Germany
Tamiflu 30 mg hard capsules: EU/1/02/222/003
Tamiflu 45 mg hard capsules: EU/1/02/222/004
Tamiflu 75 mg hard capsules: EU/1/02/222/001
Date of first authorisation: 20 June 2002
Date of last renewal: 22 May 2012
| Drug | Countries | |
|---|---|---|
| TAMIFLU | Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
